Analyst Ranking
Bottom 5%
#4797 out of 5002 analysts
Average Return
-7.14%
Win Rate
39%29 out of 74
Risk vs Reward
Poor
Good

Paul Matteis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Rhythm Pharmaceuticals IncRYTM
+91.98%$52.97$101.69
2025-03-04 -
2025-09-03
Strong Buy
Sionna Therapeutics IncSION
+65.88%$14.80$24.55
2025-03-03 -
2025-09-03
Strong Buy
Alnylam Pharmaceuticals IncALNY
+65.70%$270.02$447.43
2025-03-30 -
2025-09-03
Strong Buy
Gw Pharmaceuticals PLCGWPH
+64.79%$98.51$162.33
2017-10-01 -
2018-10-02
Buy
Rhythm Pharmaceuticals IncRYTM
+64.33%$61.88$101.69
2025-05-28 -
2025-09-03
Strong Buy

Paul Matteis Analyst Color

Get additional color on Paul Matteis's coverage of popular stocks

Paul Matteis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Vertex Pharmaceuticals IncVRTX
14Hold$455.00+14.72%Maintains
a month ago
Neurocrine Biosciences IncNBIX
6Strong Buy$174.00+27.84%Maintains
a month ago
Dyne Therapeutics IncDYN
4Strong Buy$36.00+167.06%Maintains
a month ago
Rhythm Pharmaceuticals IncRYTM
2Strong Buy$94.00-7.56%Maintains
3 months ago
Vigil Neuroscience IncVIGL
2Hold$8.00-0.62%Downgrades
3 months ago
Alnylam Pharmaceuticals IncALNY
8Strong Buy$345.00-22.89%Maintains
5 months ago
Neumora Therapeutics IncNMRA
2Hold$2.00+14.29%Downgrades
6 months ago
Sionna Therapeutics IncSION
1Strong Buy$32.00+30.35%Initiates Coverage On
6 months ago
Gh Research PLCGHRS
2Strong Buy$32.00+128.25%Maintains
6 months ago
Compass Pathways PLCCMPS
1Strong Buy$11.00+133.55%Initiates Coverage On
6 months ago
Uniqure NvQURE
1Strong Buy$32.00+84.12%Maintains
9 months ago
Sage Therapeutics IncSAGE
5Hold$6.00-30.88%Maintains
9 months ago
Denali Therapeutics IncDNLI
3Strong Buy$37.00+141.67%Upgrades
9 months ago
Alector IncALEC
5Hold$4.00+43.37%Downgrades
9 months ago
Alto Neuroscience IncANRO
3Strong Buy$10.00+177.01%Maintains
10 months ago
Neurogene IncNGNE
2Strong Buy$60.00+201.96%Maintains
10 months ago
Alkermes PLCALKS
5Strong Buy$36.00+20.00%Upgrades
10 months ago
Biomarin Pharmaceutical IncBMRN
8Strong Buy$87.00+47.51%Maintains
a year ago
Rapport Therapeutics IncRAPP
1Strong Buy$35.00N/AInitiates Coverage On
a year ago
Ionis Pharmaceuticals IncIONS
4Hold$53.00N/AMaintains
a year ago
Acadia Pharmaceuticals IncACAD
5Hold$21.00N/AMaintains
a year ago
Contineum Therapeutics IncCTNM
1Strong Buy$29.00N/AInitiates Coverage On
a year ago
Biogen IncBIIB
6Strong Buy$287.00N/AMaintains
2 years ago
Lexeo Therapeutics IncLXEO
1Strong Buy$20.00N/AInitiates Coverage On
2 years ago
Vistagen Therapeutics IncVTGN
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
Pepgen IncPEPG
2Strong Buy$24.00N/AReiterates
2 years ago
Karuna Therapeutics IncKRTX
3Strong Buy$295.00N/AMaintains
3 years ago
Cerevel Therapeutics Holdings IncCERE
2Strong Buy$54.00N/AMaintains
3 years ago
Athira Pharma IncATHA
2Hold$5.00N/ADowngrades
3 years ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$32.00N/AMaintains
3 years ago
Climb Bio IncCLYM
1Strong Buy$35.00N/AInitiates Coverage On
4 years ago
Acumen Pharmaceuticals IncABOS
1Strong Buy$27.00N/AInitiates Coverage On
4 years ago
Prevail Therapeutics IncPRVL
1Strong Buy$23.00N/AInitiates Coverage On
5 years ago
Gw Pharmaceuticals PLCGWPH
4Hold$140.00N/ADowngrades
5 years ago
Avadel Pharmaceuticals PLCAVDL
1Strong Buy$14.00N/AInitiates Coverage On
5 years ago
Zogenix IncZGNX
3Buy$60.00N/AInitiates Coverage On
7 years ago
Acorda Therapeutics IncACORQ
1Hold$2,280.00N/AMaintains
7 years ago
Akcea Therapeutics IncAKCA
2Hold$31.00N/AMaintains
7 years ago
Obseva SaOBSVF
1Buy$18.00N/AMaintains
8 years ago
Wave Life Sciences LtdWVE
1Buy$64.00N/AMaintains
8 years ago
Cidara Therapeutics IncCDTX
1Buy$340.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.